What is Buvidal 16 mg, Depot-injection solution used for?

( ARTG ) Buvidal Monthly is indicated for maintenance treatment of opioid dependence with prior stabilisation on Buvidal Weekly or sublingual buprenorphine or buprenorphine/naloxone within a framework of medical, social and psychological support.

What are the side effects of Buvidal 16 mg, Depot-injection solution?

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Can Buvidal 16 mg, Depot-injection solution be used during pregnancy?

( AHT ) For the active ingredient buprenorphine You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What ATC class does Buvidal 16 mg, Depot-injection solution belong to?

Buvidal 16 mg, Depot-injection solution: ATC N07BC01. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Buvidal 16 mg, Depot-injection solution

Data updated: 2026-04-11

Available in:

🇨🇿🇩🇪🇬🇧🇸🇰

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

Future Health Pharma GmbH

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.